Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

ConditionsLevonorgestrel Intrauterine Systems Prevention Endometrial Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorM.D. Anderson Cancer Center

About this trial

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Unaffected women

Must be at least 18 years old

Must read and speak English or Spanish

Must be premenopausal

Disqualifiers

N/A

Trial population

MD Anderson Cancer Center

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

Survey using a questionnaire
Other intervention
Patient Preference Utility Assessment and Questionnaires

Treatment groups

270 Participants

are divided into 2 treatment groups

Group A: Phase 11 intervention

Group B: Phase 21 intervention

Trial outcomes

Primary outcomes

Patient Utility Questionnaire

Time frame

Through study completion; an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

Cancer Prevention Research Institute of Texas

Collaborator

Source ClinicalTrials.gov

Apply now